Newsroom
Sorted by: Latest
-
Dialed Moods Advances Biohacking Wellness with Nature-Driven Supplement Innovation
COSTA MESA, Calif.--(BUSINESS WIRE)--Dialed Moods, a leading health and wellness company, expands its focus in 2026 on holistic biohacking through plant-powered formulations. Dialed Moods products enable individuals to integrate biohacking into their routines through clean, accessible supplements. The brand’s natural supplement offerings are designed to help consumers optimize physical performance, mental clarity and everyday vitality. Each product is crafted with carefully selected botanicals,...
-
HELLENiQ ENERGY and Chevron Sign Offshore Concession Agreements for Hydrocarbon Exploration and Production with the Hellenic Republic
ATHENS, Greece--(BUSINESS WIRE)--HELLENiQ ENERGY, in collaboration with Chevron, signed today the Lease Agreements with the Hellenic Republic for the exploration of four offshore blocks located south of Crete and the Peloponnese, marking a significant milestone for Greece’s upstream development. The successful consortium, with Chevron at 70% interest and being the Operator and HELLENiQ ENERGY at 30% interest, was selected following a competitive international tender launched by the Greek State...
-
Poxel Reports its 2025 Revenue and Provides an Update on its Financial Position
LYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic dysfunction-associated steatohepatitis (MASH) and rare metabolic disorders, reports today its annual revenue for the fiscal year ended December 31, 2025, and provides an update on its financial position. Consolidated Revenue Poxel generated consolidat...
-
Poxel publie son chiffre d’affaires pour l’exercice 2025 et fait le point sur sa situation financière
LYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), société biopharmaceutique au stade clinique développant des traitements innovants pour les maladies chroniques graves à physiopathologie métabolique, dont la stéatohépatite associée à un dysfonctionnement métabolique (MASH) et les maladies métaboliques rares, publie aujourd'hui son chiffre d'affaires annuel pour l’exercice clos au 31 décembre 2025 et fait le point sur sa situation financière. Chiffre d’a...
-
PLATO Publishes Revised ANSI/PLATO FL 1 Standard, Introducing First Industry Standard for Turbo / Boost Brightness Measurement
MINNEAPOLIS--(BUSINESS WIRE)--The Portable Lights American Trade Organization (PLATO) today announced the publication of the revised ANSI/PLATO FL 1 Standard, marking the most significant update in the Standard’s history and reinforcing its role as the global benchmark for portable lighting performance measurement and reporting. Originally introduced in 2009, the ANSI/PLATO FL 1 Standard established a uniform framework for measuring and communicating key performance metrics such as light output...
-
Tom Pritzker Retires as Executive Chairman of Hyatt After 22 Years of Service and Will Not Stand for Reelection to Board of Directors
CHICAGO--(BUSINESS WIRE)--Thomas J. Pritzker, 75, Executive Chairman of Hyatt Hotels Corporation (NYSE: H) today released a letter, previously shared with the Board of Hyatt, explaining his decision to retire as Executive Chairman, effective immediately, and not to stand for reelection to the Board at the 2026 Annual Meeting of Stockholders. Mr. Pritzker said, “My job and responsibility is to provide good stewardship. That is important to me. Good stewardship includes ensuring a proper transiti...
-
Rosen Law Firm Urges REGENXBIO, Inc. (NASDAQ: RGNX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of REGENXBIO, Inc. (NASDAQ: RGNX) between February 9, 2022 and January 27, 2026, inclusive (the “Class Period”). REGENXBIO is a clinical-stage biotechnology company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that REGENXBIO, Inc...
-
Klarna disponible sur Google Pay au Royaume-Uni
LONDRES--(BUSINESS WIRE)--Klarna, la banque numérique mondiale et fournisseur de solutions de paiement flexibles, est désormais disponible sur Google Pay au Royaume-Uni. Les utilisateurs de Google Pay au Royaume-Uni peuvent choisir les options de paiement sans intérêt de Klarna lors du paiement. Raji Behal, directeur de Klarna pour l'Europe occidentale et méridionale, le Royaume-Uni et l'Irlande, a déclaré : « Nous sommes ravis d'offrir aux utilisateurs de Google Pay les options de paiement équ...
-
Trafficmind Expands Global Anycast Network for Performance-Critical and Regulated Workloads
LAUSANNE, Switzerland--(BUSINESS WIRE)--Trafficmind.com today announced the expansion of its global Anycast network with the addition of new edge capacity in Osaka, Japan. The expansion strengthens support for latency-sensitive and compliance-driven workloads across the Asia-Pacific region. The Osaka deployment adds 100 Gbps of edge capacity and is hosted within carrier-neutral facilities operated by Equinix. This increases regional proximity, resilience, and throughput for customers serving us...
-
Riassunto: Klarna arriva su Google Pay nel Regno Unito
LONDRA--(BUSINESS WIRE)--Klarna, banca digitale globale e fornitore di pagamenti flessibili, è ora disponibile in Google Pay nel Regno Unito. Al checkout, gli utenti di Google Pay nel Regno Unito possono scegliere le opzioni di pagamento a zero interessi di Klarna. Raji Behal, Responsabile per l'Europa occidentale e meridionale, Regno Unito e Irlanda di Klarna, ha dichiarato, “Siamo davvero entusiasti di portare le opzioni di pagamento trasparenti, flessibili e a zero interessi di Klarna agli u...